Table 1 List of participating studies and number of case and control subjects
From: Reproductive aging-associated common genetic variants and the risk of breast cancer
Study acronym | Study name | Study design | Case subjects (n= 3,683) | ER+/ER- subjects (n = 1,716/371) | Control subjects (n = 34,174) | All subjects (n = 37,857) |
|---|---|---|---|---|---|---|
NHS-BC | Nurses' Health Study-Breast Cancer | Nested case-control | 1,145 (31.1) | 807/181 | 1,142 (3.3) | 2,287 (6.0) |
WGHS | Women's Genome Health Study | Prospective cohort | 1,099 (29.8) | 909/190 | 22,205 (65.0) | 23,304 (61.5) |
SardBC | SardiNIA Breast Cancer Study | Case-control | 809 (22.0) | - | 674 (2.0) | 1,483 (3.9) |
RSI+II | Rotterdam Study I and II | Prospective cohort | 216 (5.9) | - | 4,261 (12.5) | 4,477 (11.8) |
FHS | Framingham Heart Study | Prospective cohort | 207 (5.6) | - | 3,698 (10.8) | 3,905 (10.3) |
ARIC | Atherosclerosis Risk in Communities Study | Prospective cohort | 207 (5.6) | - | 2,194 (6.4) | 2,401 (6.3) |